Press Releases

All Releases
Jan 07, 2020
AngioDynamics Reports Fiscal 2020 Second Quarter Financial Results
Fiscal 2020 Second Quarter Highlights Net sales of $70.0 million , flat compared to the prior-year quarter Gross margin increased 140 basis points year over year to 59.3% GAAP loss per share of $0.07 ; adjusted earnings per share of $0.06 Announces the acquisition of C3 Wave PICC tip location
Jan 06, 2020
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Jan. 6, 2020-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer , President and Chief Executive Officer, and
Oct 03, 2019
AngioDynamics Reports Fiscal 2020 First Quarter Financial Results
  Fiscal 2020 First Quarter Highlights         Net sales of $66.0 million , an increase of 3.3% year over year       Gross margin increased 170 basis points year over year to 57.9%       GAAP loss per share of $0.03 ; adjusted earnings per share of $0.08         LATHAM, N.Y. --(BUSINESS WIRE)--Oct.
Jul 23, 2019
AngioDynamics to Present at the Canaccord Genuity Growth Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Jul. 23, 2019-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer , President and Chief Executive Officer, will
Displaying 1 - 20 of 653